2009/05/19 by Gabriel Louw, Robin M. Warren, Nicolaas C. Gey van Pittius +3 · 259 citations
Medicine · #Tuberculosis Research and Epidemiology #Mycobacterium research and diagnosis #Pneumocystis jirovecii pneumonia detection and treatment #Efflux #Drug resistance #Drug #Pharmacology #Microbiology #Medicine #Biology #Biochemistry
paper · open access · doi:10.1128/aac.01577-08
published in Antimicrobial Agents and Chemotherapy 53(8), 3181-3189 (American Society for Microbiology)
openalex publication_date 2009/05/19 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/18
Since the discovery of the tubercle bacillus by Robert Koch in 1882 ([110][1]), a greater understanding of the dynamics and survival mechanisms of this pathogen has led to more questions than answers. Despite stringent control strategies and many advances in our knowledge of the epidemiology of